Published in J Cancer Res Clin Oncol on February 27, 2014
Ovarian cancer risk reduction through opportunistic salpingectomy. J Gynecol Oncol (2015) 0.76
Menopausal hormone therapy and breast cancer mortality: clinical implications. Ther Adv Drug Saf (2015) 0.75
Should Fallopian Tubes Be Removed During Hysterectomy Procedures? - A Statement by AGO Ovar. Geburtshilfe Frauenheilkd (2015) 0.75
Feasibility and safety of outpatient total laparoscopic hysterectomy. JSLS (2015) 0.75
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13
ASA physical status classifications: a study of consistency of ratings. Anesthesiology (1978) 7.23
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol (2007) 5.68
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol (2006) 3.96
Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol (2007) 3.94
The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol (2007) 3.02
Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol (2010) 2.65
Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol (2013) 1.92
Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance. Int J Gynecol Pathol (2009) 1.62
Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization. J Minim Invasive Gynecol (2013) 1.50
The post-reproductive Fallopian tube: better removed? Hum Reprod (2011) 1.31
Fallopian tube disease in the nonpregnant patient. Radiographics (2011) 1.27
Tubal ligation and the risk of ovarian cancer: review and meta-analysis. Hum Reprod Update (2010) 1.26
Global ovarian cancer health disparities. Gynecol Oncol (2012) 1.24
The risk of hydrosalpinx formation and adnexectomy following tubal ligation and subsequent hysterectomy: a historical cohort study. Am J Obstet Gynecol (2006) 1.11
Combined laparoscopic and vaginal surgery for the management of two cases of stage I endometrial cancer. Gynecol Oncol (1992) 1.06
Tubal ligation and risk of ovarian cancer. Lancet (2001) 1.04
Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res (2007) 1.04
Ovarian function before and after salpingectomy in artificial reproductive technology patients. Hum Reprod (2000) 0.91
Five minutes of extended assisted ventilation with an open umbilical trocar valve significantly reduces postoperative abdominal and shoulder pain in patients undergoing laparoscopic hysterectomy. Eur J Obstet Gynecol Reprod Biol (2013) 0.90
Prophylactic salpingectomy does not impair the ovarian response in IVF treatment. Hum Reprod (2001) 0.88
Effect of the removal of the Fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome. Eur J Obstet Gynecol Reprod Biol (2009) 0.83
Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? BJOG (2009) 0.81
Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977-2010. BMJ Open (2013) 0.79
Three-dimensional ultrasound inversion rendering technique facilitates the diagnosis of hydrosalpinx. J Clin Ultrasound (2010) 0.78
p53 mutant His175 identified in a newly established fallopian tube carcinoma cell line secreting interleukin 6. FEBS Lett (1994) 0.78
Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx? Am J Obstet Gynecol (2002) 0.78
Müllerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol. Mod Pathol (2013) 0.78
Inhibin B and ovarian function after total abdominal hysterectomy in women of reproductive age. Gynecol Endocrinol (2003) 0.77
An unusual case of torsion hydrosalpinx after hysterectomy: a case report. Aust N Z J Obstet Gynaecol (2007) 0.77
Laparoscopically-assisted vaginal hysterectomy (LAVH)--an alternative to abdominal hysterectomy. Singapore Med J (2002) 0.75
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet (1995) 1.84
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res (2001) 1.59
The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann N Y Acad Sci (2010) 1.46
p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol (1999) 1.45
Laparoscopic lymphocele fenestration in gynaecological cancer patients after retroperitoneal lymph node dissection as a first-line treatment option. BJOG (2013) 1.42
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. Ann Oncol (2007) 1.42
Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Oncogene (2008) 1.40
Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene (2007) 1.37
Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice. Oncogene (2010) 1.19
p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res (1998) 1.13
Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice. Eur J Clin Invest (2006) 1.09
CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta. Gene Ther (2003) 1.09
Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J Physiol Pharmacol (2005) 1.06
Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol (2009) 1.05
Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass. Br J Cancer (2000) 1.04
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. Br J Cancer (1999) 1.03
Surgical management of multiple bilateral fibroadenoma of the breast: the Ribeiro technique modified by Rezai. Anticancer Res (2009) 1.00
Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients. Anticancer Res (1998) 0.97
Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells. Cancer Gene Ther (2001) 0.94
p53 autoantibodies in patients with primary ovarian cancer are associated with higher age, advanced stage and a higher proportion of p53-positive tumor cells. Oncology (1999) 0.94
[Evaluation of a cell block method in cytological diagnostics]. Pathologe (2012) 0.94
Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin. Int J Cancer (1998) 0.93
Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues. J Biol Inorg Chem (2010) 0.92
Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Res (2000) 0.91
Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy. Rofo (2011) 0.91
Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer (2005) 0.88
Laparascopically assisted vaginal resection of rectovaginal endometriosis. Obstet Gynecol (2000) 0.87
Chicken ovalbumin upstream promoter transcription factor (COUP-TF): an orphan steroid receptor with a specific pattern of differential expression in human ovarian cancer cell lines. Gynecol Oncol (1993) 0.86
[Diagnosis and treatment of necrotizing fasciitis of the head and neck region]. Laryngorhinootologie (2000) 0.86
Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinoma. J Cancer Res Clin Oncol (2011) 0.86
The effect of montelukast on atherogenesis in apoE/LDLR-double knockout mice. J Physiol Pharmacol (2008) 0.86
Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature. J Cancer Res Clin Oncol (2013) 0.86
Inhibition of nuclear factor-kappaB attenuates artherosclerosis in apoE/LDLR - double knockout mice. J Physiol Pharmacol (2005) 0.85
Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines. Anticancer Res (1997) 0.85
Targeted delivery of liposomal dexamethasone phosphate to the spleen provides a persistent therapeutic effect in rat antigen-induced arthritis. Ann Rheum Dis (2009) 0.84
Placental Schistosoma haematobium infection in a German returnee from Malawi. Infection (2014) 0.84
Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice. J Physiol Pharmacol (2012) 0.83
Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3. Hum Gene Ther (2001) 0.83
Chicken ovalbumin upstream promoter--transcription factor (COUP-TF) expression in human endometrial cancer cell lines. Anticancer Res (1997) 0.83
Solitons as the early stage of quasicondensate formation during evaporative cooling. Phys Rev Lett (2011) 0.82
Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations. Clin Cancer Res (1997) 0.82
Treatment of endometriosis of uterosacral ligament and rectum through the vagina: description of a modified technique. Hum Reprod (2009) 0.82
Venous coupler for free-flap anastomosis. Anticancer Res (2009) 0.81
Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast. Br J Cancer (1999) 0.81
Is the decision for colorectal resection justified by histopathologic findings: a prospective study of 100 patients with advanced ovarian cancer. Gynecol Oncol (2001) 0.81
Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients. Int J Mol Med (2000) 0.80
Human papillomavirus integration is not associated with advanced epithelial ovarian cancer in German patients. Cancer Epidemiol Biomarkers Prev (1995) 0.80
AVE 0991-angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice. J Physiol Pharmacol (2010) 0.80
The effect of nebivolol on atherogenesis in apoE-knockout mice. J Physiol Pharmacol (2009) 0.79
Characterisation of Atherogenic Effects of Low Carbohydrate, High Protein Diet (LCHP) in ApoE/LDLR-/- Mice. J Nutr Health Aging (2015) 0.79
Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors. Ann Oncol (2008) 0.78
Effects of margarine supplemented with t10c12 and C9T11 CLA on atherosclerosis and steatosis in apoE/LDLR -/- mice. J Nutr Health Aging (2012) 0.78
Transarterial catheter embolization of a sarcoma for preoperative conditioning. Vasa (2010) 0.78
Downsizing a tumor thrombus of advanced renal cell carcinoma with neoadjuvant systemic therapy and resulting histopathological effects. Urol Int (2010) 0.78
BAY x 1005 attenuates atherosclerosis in apoE/LDLR - double knockout mice. J Physiol Pharmacol (2007) 0.78
Potential of MR mammography to predict tumor grading of invasive breast cancer. Rofo (2011) 0.77
[Vulvodynia]. Hautarzt (2005) 0.77
Functional implications of extensive new data on the innervation of pulmonary neuroepithelial bodies. Ital J Anat Embryol (2001) 0.77
Sentinel lymph node biopsy in vulvar cancer: a pilot study. Eur J Gynaecol Oncol (2009) 0.77
Multimode dynamics of a coupled ultracold atomic-molecular system. Phys Rev Lett (2001) 0.77
Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria. Virchows Arch (2012) 0.77
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL). Anticancer Res (1994) 0.77
[Adult multilocular rhabdomyoma as etiology of a space-occupying lesion in the area of the neck]. HNO (2001) 0.77
Effect of nebivolol treatment on atherosclerotic plaque components in apoE-knockout mice. J Physiol Pharmacol (2013) 0.77
The effect of doxycycline on atherogenesis in apoE-knockout mice. J Physiol Pharmacol (2011) 0.76
Neoplastic disorders of prostate glands in the light of synchrotron radiation and multivariate statistical analysis. J Biol Inorg Chem (2011) 0.75
On coherence of Bose field. Opt Express (2001) 0.75
Multi-mode description of an interacting Bose-Einstein condensate. Opt Express (2001) 0.75
Can color-coded parametric maps improve dynamic enhancement pattern analysis in MR mammography? Rofo (2009) 0.75
[Intraluminal hypertension as a pathogenetic factor of acute pancreatitis in the rat (author's transl)]. Z Gastroenterol (1980) 0.75
[Diagnostic pitfalls with Cushing's syndrome]. Internist (Berl) (2010) 0.75
Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitro. J Cancer Res Clin Oncol (2000) 0.75
[Rare differential diagnosis in a 40-year old patient with sleep apnea syndrome]. HNO (2012) 0.75
[Intracardiac metastases of hepatocellular carcinoma]. Rofo (2009) 0.75
Soliton trains in Bose-Fermi mixtures. Phys Rev Lett (2004) 0.75
[A 64-year-old female patient with recurring hypoglycaemia. Difficult aspects of diagnosis]. Internist (Berl) (2007) 0.75
[Miliary tuberculosis during therapy with a tumor necrosis factor blocker--modern therapy, an old problem]. Rofo (2008) 0.75
Modulation of soluble CD44 concentrations by hormone and anti-hormone treatment in gynecological tumor cell lines. Oncol Rep (2001) 0.75
[Case of incomplete prune belly syndrome in a 3 1/2-month-old boy]. Pediatr Pol (1980) 0.75
[Spontaneous rupture of the abdominal aorta in Ehlers-Danlos syndrome]. Rofo (2008) 0.75
Large mediastinal sarcoma in a patient with Gorlin-Goltz syndrome. Thorac Cardiovasc Surg (2006) 0.75
Value of ductal obstruction sign in the differentiation of benign and malignant breast lesions at MR imaging. Eur J Radiol (2009) 0.75
[Choriocarcinoma]. Rofo (2006) 0.75